Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.
Human insulin and its precursor, mini-proinsulin, made with a new biosynthetic method, were tested for their receptor binding, biologic action, and antibody binding ability. The structure of mini-proinsulin is similar to that of proinsulin with a shortened C-peptide, B(1-29)-Ala-Ala-Lys-A(1-21) insulin. The ability of biosynthetic human insulin to bind to receptors, to stimulate 2-deoxyglucose uptake in isolated adipocytes, and to bind to insulin antibody was comparable to that of semisynthetic human insulin. The ability of mini-proinsulin to bind to insulin receptors and to stimulate 2-deoxyglucose uptake in adipocytes was 0.5 and 0.2% that of human insulin, whereas the corresponding abilities of proinsulin were 5 and 3%, respectively. Despite having less receptor binding and biologic activity, mini-proinsulin demonstrated higher affinity for the insulin antibody than did proinsulin. These results suggest that biosynthetic human insulin behaves similarly to semisynthetic human insulin in its receptor binding and biologic activity, and that the shortened C-peptide region reduces receptor binding by fixing or covering the N-terminal region of the A chain, which is important for receptor binding.
Kobayashi
M
M
Third Department of Medicine, Shiga University of Medical Science, Japan.
Sasaoka
T
T
Sugibayashi
M
M
Iwanishi
M
M
Shigeta
Y
Y
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D003001:Cloning, Molecular; D004274:DNA, Recombinant / Q000378:metabolism; D003847:Deoxyglucose / Q000378:metabolism; D005796:Genes; D006801:Humans; D007328:Insulin / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D008214:Lymphocytes / Q000378:metabolism; D011384:Proinsulin / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats; D011972:Receptor, Insulin / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D012441:Saccharomyces cerevisiae / Q000235:genetics; D013552:Swine
D004274:DNA, Recombinant; D007328:Insulin; D011994:Recombinant Proteins; D011384:Proinsulin; D003847:Deoxyglucose; D011972:Receptor, Insulin